Physician profile
Nancy E Young
NPI 1457394553
$1,821.80
in general payments reported to CMS, 2019-2025
16 companies · $667 in 2025
The $667 reported for 2025 was more than what 94% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $92.88 · 2023: $425 · 2024: $521 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $286.88 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Alnylam Pharmaceuticals INC. | $169.17 | 2023-2024 | Givlaari, Oxlumo |
| Boston Scientific Corporation | $142.29 | 2025 | Watchman Flx |
| Pharming Healthcare, INC. | $130.00 | 2024 | Ruconest |
| Neurocrine Biosciences, INC. | $128.79 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.33 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $108.98 | 2025 | Evkeeza |
| Genentech USA, INC. | $92.88 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $90.41 | 2023 | Farxiga |
| Lexicon Pharmaceuticals, INC. | $90.37 | 2024 | Inpefa |
| Seqirus USA INC | $87.42 | 2023 | |
| Horizon Therapeutics Plc | $78.41 | 2023 | Uplizna |
| Amgen INC. | $77.06 | 2024 | Uplizna |
| Ironshore Pharmaceuticals INC. | $77.05 | 2023 | Jornay Pm |
| Genzyme Corporation | $74.35 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $71.41 | 2024 | Venaseal, Closurefast |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.